• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Classics Emergency Classics

The ARMA trial: Lower tidal volume ventilation in ALI/ARDS [Classics Series]

byMilana Bogorodskaya, MDandAndrew Cheung, MD MBA
August 15, 2014
in Emergency Classics, General Medicine Classics, Surgery Classics, The Classics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. The trial was terminated early when the data demonstrated that lower tidal volume ventilator settings in ALI/ARDS patients led to a significant decrease in in-hospital mortality.

2. Low tidal volume ventilation also led to an increase in ventilator-free days and a decrease in the number of days with systemic organ failure. There was no change in the incidence of barotrauma between the two groups.

3. Patients assigned to lower tidal volume ventilator settings initially required a higher PEEP to maintain arterial oxygenation and were more likely to develop respiratory acidosis, although the difference disappeared by day 7.

Original Date of Publication: May 4, 2000

Study Rundown: Traditionally, patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) requiring mechanical ventilation were subjected to higher tidal volumes (10-15 mL/kg) than a healthy individual, in an effort to maintain normal partial pressure of carbon dioxide and arterial pH. However, studies in animals showed that higher tidal volumes were associated with increased lung inflammation and injury. This multi-center, randomized, controlled trial compared traditional tidal volume therapy (12 mL/kg) to low tidal volume therapy (6 mL/kg) in mechanically ventilated patients with ALI/ARDS for 28 days. Results showed that the traditional tidal volume group had significantly increased in-hospital mortality compared to the low tidal volume group (p=0.007). There was no difference in barotrauma between the two groups.

In summary, this study demonstrates that lower tidal volumes in ALI/ARDS patients reduced in-hospital mortality and the number of days that patients required use of the ventilator. Of note, patients in the lower tidal volume group required higher PEEP and had a slight, but significant, respiratory acidosis, both of which resolved after 7 days. This suggests that though lower tidal volumes required a higher respiratory rate to maintain adequate ventilation, its benefits on mortality outweighed the transient acid/base and oxygenation imbalances that were effectively managed with higher PEEP and sodium bicarbonate infusion, respectively.

Click to read the study in NEJM

RELATED REPORTS

#VisualAbstract: Early mobilization after ICU mechanical ventilation does not improve survival

Pressure support ventilation does not improve ventilation status as compared to T-piece ventilation

#VisualAbstract: Tocilizumab reduced COVID-19 disease related adverse health outcomes

Click to read an accompanying editorial in NEJM

In-Depth [randomized, controlled trial]: Originally published in 2000 in NEJM, this trial was conducted at 10 university centers across the United States from 1996-1999. Eligible patients were all patients above the age of 18 who were intubated and mechanically ventilated and had an acute decrease to a P/F ratio (partial pressure of arterial oxygen to fraction of inspired oxygen) of 300 or less with evidence of bilateral lung edema on recent chest x-ray. Patients with chronic lung disease, high pulmonary capillary wedge pressure or evidence of left atrial hypertension, less than 6 months of estimated survival, and other medical problems that would cause poor respiration or oxygenation, were excluded. Patients were randomized to traditional tidal volume therapy of 12 mL/kg or low tidal volume therapy of 6 mL/kg for 28 days. Patients were followed up weekly for a total of 180 days. The primary endpoint was in-hospital mortality, with significant reduction from 39.8% in the traditional group to 31.0% in the low tidal volume group (p=0.007, 95% CI 2.4-15.3%). There was also a significant decrease in the number of ventilator-free days in the low tidal volume group (p=0.007) and in the number of days free from organ failure (p=0.006).

Image: PD

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

Tags: ARDSPEEPventilation
Previous Post

Vitamin E associated with slower functional decline in Alzheimer disease [TEAM-AD Trial]

Next Post

Increased ER use among newly insured: Oregon Health Insurance Experiment

RelatedReports

#VisualAbstract: Early mobilization after ICU mechanical ventilation does not improve survival
StudyGraphics

#VisualAbstract: Early mobilization after ICU mechanical ventilation does not improve survival

December 1, 2022
Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure
Emergency

Pressure support ventilation does not improve ventilation status as compared to T-piece ventilation

November 18, 2022
#VisualAbstract: Tocilizumab reduced COVID-19 disease related adverse health outcomes
StudyGraphics

#VisualAbstract: Tocilizumab reduced COVID-19 disease related adverse health outcomes

March 10, 2021
#VisualAbstract: Tocilizumab reduced COVID-19 disease related adverse health outcomes
StudyGraphics

#VisualAbstract: Hospitalized COVID-19 patients show decrease in mortality with dexamethasone

March 9, 2021
Next Post
Low diastolic blood pressure associated with higher mortality in chronic kidney disease

Increased ER use among newly insured: Oregon Health Insurance Experiment

Teens who text and drive take other driving risks

Road distractions are significant risk factors for motor vehicle crashes

5-FU a promising treatment for CIN-2

5-FU a promising treatment for CIN-2

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transcarotid artery revascularization not associated with a significant difference in 30-day risk of stroke, death and myocardial infarction compared to carotid endarterectomy
  • Drinking characteristics in adolescence predict alcohol behaviors in early adulthood
  • Sodium-glucose co-transporter-2 inhibitors may decrease risk of in-stent thrombosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options